Invention Grant
- Patent Title: Substituted imidazoquinoline derivatives as kinase inhibitors
- Patent Title (中): 取代的咪唑并喹啉衍生物作为激酶抑制剂
-
Application No.: US13810431Application Date: 2011-07-15
-
Publication No.: US09062046B2Publication Date: 2015-06-23
- Inventor: Sanjay Kumar , Rajiv Sharma , Robert Zahler , Bichismita Sahu , Veena R. Agarwal , Nishigandha Naik
- Applicant: Sanjay Kumar , Rajiv Sharma , Robert Zahler , Bichismita Sahu , Veena R. Agarwal , Nishigandha Naik
- Applicant Address: IN Mumbai
- Assignee: Piramal Enterprises Limited
- Current Assignee: Piramal Enterprises Limited
- Current Assignee Address: IN Mumbai
- Agency: Ladas & Parry LLP
- International Application: PCT/IB2011/053161 WO 20110715
- International Announcement: WO2012/007926 WO 20120119
- Main IPC: A61K31/43
- IPC: A61K31/43 ; C07D471/00 ; C07D491/00 ; C07D498/00 ; C07D513/00 ; C07D515/00 ; C07D471/04 ; A61K31/4745
Abstract:
The present invention relates to substituted imidazo[4,5-c]quinoline derivatives, the compounds of formula (I), wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of formula (I), and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammatory diseases and angiogenesis related disorders.
Public/Granted literature
- US20130116248A1 SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS Public/Granted day:2013-05-09
Information query
IPC分类:
